The store will not work correctly when cookies are disabled.
5-(5-Phenyl-penta-2,4-dienylidene)-2-thioxo-dihydropyrimidine-4,6-dione .
ID: ALA4168259
PubChem CID: 145952994
Max Phase: Preclinical
Molecular Formula: C15H12N2O2S
Molecular Weight: 284.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=S)NC(=O)C1=C/C=C/C=C/c1ccccc1
Standard InChI: InChI=1S/C15H12N2O2S/c18-13-12(14(19)17-15(20)16-13)10-6-2-5-9-11-7-3-1-4-8-11/h1-10H,(H2,16,17,18,19,20)/b6-2+,9-5+
Standard InChI Key: ZKKYXFNAVPQLOP-VDESZNBCSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
9.2428 -6.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9505 -6.5003 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6583 -6.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6583 -7.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9505 -8.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2428 -7.7269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3702 -6.5003 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9505 -8.9535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5350 -6.5003 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.3702 -8.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0780 -7.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7857 -8.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4935 -7.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2054 -8.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9132 -7.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9132 -6.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6210 -6.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3329 -6.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3329 -7.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6210 -8.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
14 15 1 0
4 10 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.34 | Molecular Weight (Monoisotopic): 284.0619 | AlogP: 1.71 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.44 | CX Basic pKa: ┄ | CX LogP: 2.73 | CX LogD: 2.45 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.38 | Np Likeness Score: -0.25 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |